Cytogen, Inc. Stock

A217330

KR7217330000

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2026-07-16			5-day change	1st Jan Change
3,050.00 ^KRW	-1.13%		-2.09%	-66.07%

05-17	Cytogen, Inc. announced that it expects to receive KRW 5.2 billion in funding from BNK Securities Co.,Ltd., Hanyang Securities Co. Ltd. and other investors.	CI
11-05	Cytogen wins 1 billion won order	RE

Cytogen Inc is a Korea-based company mainly engaged in the provision of liquid biopsy application services. The liquid biopsy application services include biomarker discovery and verification services, as well as liquid biopsy-based precision medical services which is the commercialization of companion diagnostics (CDx) development, among others. The biomarker discovery and verification services include circulating tumor cell (CTC)-based biomarker discovery and validation, gene mutation and transcript expression analysis, and drug testing and analysis services, among others. The liquid biopsy-based precision healthcare services include companion diagnosis, re-selection of therapeutic drugs, examination and treatment effectiveness monitoring, and recurrence prediction services, among others. In addition, the Company develops and sells platforms and kits for liquid biopsy. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-07-16	₩3,050.00	-1.13%	54,325
26-07-15	₩3,085.00	+3.01%	68,264
26-07-14	₩2,995.00	+0.67%	80,004
26-07-13	₩2,975.00	-4.49%	97,120
26-07-10	₩3,115.00	+6.31%	91,701

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Stock Market
Stocks
A217330 Stock

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	70.36B 47.32M 41.35M 38.16M 35.17M 66.29M 4.56B 67.76M 456M 179M 2.23B 178M 174M 7.68B	P/E 2024	-5.98x	P/E 2025	-16.8x
Enterprise Value	55.13B 37.07M 32.4M 29.9M 27.56M 51.94M 3.57B 53.09M 357M 141M 1.75B 139M 136M 6.02B	EV / Sales 2024	7.17x	EV / Sales 2025	7.38x
Free-Float	54.99%	Yield 2024 *	-	Yield 2025	-

05-17	Cytogen, Inc. announced that it expects to receive KRW 5.2 billion in funding from BNK Securities Co.,Ltd., Hanyang Securities Co. Ltd. and other investors.	CI
11-05	Cytogen wins 1 billion won order	RE
25-09-10	Cytogen sells 160 million won worth of own shares	RE
25-01-02	Cytogen Moves to Dual CEO Arrangement	MT
24-09-22	Cytogen, Inc.(KOSDAQ:A217330) dropped from S&P Global BMI Index	CI
24-08-21	Cytogen, Inc. announced that it has received KRW 6.500000445 billion in funding from Theragen Etex Co.,Ltd.	CI
24-07-30	Cytogen, Inc. agreed to acquire 98.95% stake in Theragen Genomecare Co. Ltd from Theragen Etex Co.,Ltd. and Daeilgen Bio for KRW 13.2 billion.	CI
24-03-19	Cytogen, Inc. announced that it has received KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors	CI
24-03-17	Cytogen, Inc. announced that it expects to receive KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors	CI
23-12-27	Cytogen, Inc. announced that it has received KRW 55.49999 billion in funding from CanDx Holdings Limited	CI
23-12-27	Cytogen, Inc. announced that it expects to receive KRW 99.999821616 billion in funding from Candx Holdings Limited	CI
23-12-18	Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion	CI
23-10-26	Cytogen, Inc. announces tranche update	CI

1 day	-1.13%
1 week	-2.09%
Current month	-3.17%
1 month	-29.15%
3 months	-29.07%
6 months	-66.04%
Current year	-66.07%

1 week	2,850	3,260
1 month	2,830	4,085
Current year	2,830	11,200
1 year	2,260	11,200
3 years	2,260	19,330
5 years	2,260	24,166.67
10 years	2,260	24,166.67

Manager	Title	Age	Since
Ji-Hun Ahn CEO	Chief Executive Officer	45	2025-01-01
Byeong-Hui Jeon CEO	Chief Executive Officer	67	2025-01-01
Young-Woong Son PRN	Corporate Officer/Principal	52	2025-03-30

Cytogen, Inc. Stock

Stocks

A217330

KR7217330000

Biotechnology & Medical Research

Valuation: Cytogen, Inc.

Chart: Cytogen, Inc.

Latest news : Cytogen, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Cytogen, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

Director	Title	Age	Since
Byeong-Hui Jeon BRD	Director/Board Member	67	2025-01-01
Nam-Ho Bang BRD	Director/Board Member	64	2024-09-22
Young-Woong Son BRD	Director/Board Member	52	2025-03-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYTOGEN, INC.	-1.13%	-2.09%	+1.84%	-82.07%	47.32M
REVOLUTION MEDICINES, INC.	+3.90%	-0.39%	+376.72%	+599.59%	39.58B
BEONE MEDICINES AG	-1.70%	+4.46%	+7.46%	+57.67%	34.69B
IQVIA HOLDINGS INC.	-2.01%	-0.76%	+26.35%	-6.83%	34.42B
CELLTRION, INC.	+0.06%	+0.34%	+2.32%	+29.30%	27.11B
ASCENDIS PHARMA A/S	+0.46%	-3.49%	-	-	16.21B
MEDPACE HOLDINGS, INC.	-0.04%	-0.09%	+68.48%	+117.39%	15.36B
EUROFINS SCIENTIFIC SE	+1.12%	+1.91%	+15.90%	+19.65%	14.05B
ICON PUBLIC LIMITED COMPANY	0.00%	+1.36%	+15.74%	-30.62%	13.02B
ABIVAX	-0.08%	-3.01%	+1,271.69%	+649.69%	11.76B
Average	+0.06%	-0.18%	+198.50%	+150.42%	20.63B
Weighted average by Cap.	+0.24%	+0.36%	+171.39%	+187.35%

	2024	2025
Net sales	10.91B 7.34M 6.41M 5.92M 5.45M 10.28M 707M 10.51M 70.72M 27.82M 346M 27.56M 26.95M 1.19B	26.05B 17.52M 15.31M 14.13M 13.02M 24.55M 1.69B 25.09M 169M 66.43M 826M 65.8M 64.36M 2.84B
Net income	-17.12B -11.51M -10.06M -9.28M -8.56M -16.13M -1.11B -16.49M -111M -43.64M -543M -43.23M -42.28M -1.87B	-12.34B -8.3M -7.25M -6.69M -6.17M -11.63M -799M -11.89M -80.01M -31.47M -391M -31.17M -30.49M -1.35B
Net Debt	-26.39B -17.75M -15.51M -14.31M -13.19M -24.87M -1.71B -25.42M -171M -67.29M -837M -66.66M -65.2M -2.88B	-15.23B -10.24M -8.95M -8.26M -7.61M -14.35M -987M -14.67M -98.74M -38.84M -483M -38.47M -37.63M -1.66B